Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Marco, Mielcarek"'
Autor:
Jonathan L. Golob, Martha M. DeMeules, Tillie Loeffelholz, Z.Z. Quinn, Michael K. Dame, Sabrina S. Silvestri, Michael C. Wu, Thomas M. Schmidt, Tina L. Fiedler, Matthew J. Hoostal, Marco Mielcarek, Jason Spence, Steven A. Pergam, David N. Fredricks
Publikováno v:
Blood Advances, Vol 3, Iss 19, Pp 2866-2869 (2019)
Externí odkaz:
https://doaj.org/article/69ffd6300fdd45849caedb6922866691
Autor:
Ayman Saad, Alison Loren, Javier Bolaños-Meade, George Chen, Daniel Couriel, Antonio Di Stasi, Areej El-Jawahri, Hany Elmariah, Sherif Farag, Krishna Gundabolu, Jonathan Gutman, Vincent Ho, Rasmus Hoeg, Mitchell Horwitz, Joe Hsu, Adetola Kassim, Mohamed Kharfan Dabaja, John Magenau, Thomas Martin, Marco Mielcarek, Jonathan Moreira, Ryotaro Nakamura, Yago Nieto, Cameron Ninos, Caspian Oliai, Seema Patel, Brion Randolph, Mark Schroeder, Dimitrios Tzachanis, Asya Nina Varshavsky-Yanovsky, Madhuri Vusirikala, Frankie Algieri, Lenora A. Pluchino
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:108-115
The NCCN Guidelines for Hematopoietic Cell Transplantation (HCT) provide an evidence- and consensus-based approach for the use of autologous and allogeneic HCT in the management of malignant diseases in adult patients. HCT is a potentially curative t
Autor:
Jason P. Cooper, Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith Shizuru, Georg-Nikolaus Franke, Michael B. Maris, Michael Boyer, Benedetto Bruno, Firoozeh Sahebi, Amelia A. Langston, Parameswaran Hari, Edward D. Agura, Søren Lykke Petersen, Richard T. Maziarz, Wolfgang Bethge, Julie Asch, Jonathan A. Gutman, Gitte Olesen, Andrew M. Yeager, Kai Hübel, William J. Hogan, David G. Maloney, Marco Mielcarek, Paul J. Martin, Mary E.D. Flowers, George E. Georges, Ann E. Woolfrey, H. Joachim Deeg, Bart L. Scott, George B. McDonald, Rainer Storb, Brenda M. Sandmaier
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
We have used a non-myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation for the past twenty years. During that period, changes in clinical practice have been aimed at reducing morbidity and mortality from infections, o
Externí odkaz:
https://doaj.org/article/b53a5c54d0c946cb9309c9ef5ead75fa
Autor:
Damian J. Green, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Leona A. Holmberg, Pamela S. Becker, Min Fang, Paul J. Martin, George E. Georges, Michelle E. Bouvier, Rainer Storb, Marco Mielcarek
Publikováno v:
Blood Advances, Vol 1, Iss 24, Pp 2247-2256 (2017)
Abstract: We evaluated tandem autologous/allogeneic hematopoietic cell transplantation followed by bortezomib maintenance therapy in a prospective phase 2 trial of treatment of high-risk multiple myeloma. The high-dose conditioning regimen for autolo
Externí odkaz:
https://doaj.org/article/488d366e6ddb479f9dd0b1f16361e44e
Autor:
Aaron Etra, Alexandra Capellini, Amin Alousi, Monzr M. Al Malki, Hannah Choe, Zachariah DeFilipp, William J. Hogan, Carrie L. Kitko, Francis Ayuk, Janna Baez, Isha Gandhi, Stelios Kasikis, Sigrun Gleich, Elizabeth Hexner, Matthias Hoepting, Urvi Kapoor, Steven Kowalyk, Deukwoo Kwon, Amelia Langston, Marco Mielcarek, George Morales, Umut Özbek, Muna Qayed, Ran Reshef, Wolf Rösler, Nikolaos Spyrou, Rachel Young, Yi-Bin Chen, James L. M. Ferrara, John E. Levine
Publikováno v:
Blood. 140:1867-1869
The standard primary treatment for acute graft-versus-host disease (GVHD) requires prolonged, high-dose systemic corticosteroids (SCSs) that delay reconstitution of the immune system. We used validated clinical and biomarker staging criteria to ident
Autor:
Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
We previously reported initial results in 102 multiple myeloma (MM) patients treated with sequential high-dose melphalan and autologous hematopoietic cell transplantation followed by 200 cGy total body irradiation with or without fludarabine 90 mg/m2
Externí odkaz:
https://doaj.org/article/16ae65b124174a7db168e63d44d26e82
Autor:
John Koreth, Alison W. Loren, Ryotaro Nakamura, Edmund K. Waller, Joseph A. Pidala, Marco Mielcarek, Cherie Tracy Ng, Lisette M Acevedo, Maple Fung, Joel Rothman, Stephen Connelly, Corey Cutler
Publikováno v:
Transplantation and Cellular Therapy. 29:S30-S31
Autor:
Jim Boonyaratanakornkit, Qianwen Wang, Ahmed Nader, Louise E. Kimball, Marta Levkova, Jeanette Nguyen, Jennifer Wright, Emily S Ford, Marco Mielcarek, Jennifer Han, Michael J. Boeckh, Dr. Alpana Waghmare
Publikováno v:
Transplantation and Cellular Therapy. 29:S329-S330
Autor:
Laura Roberts, Filippo Milano, Ted A. Gooley, Marco Mielcarek, Michael Linenberger, Effie W. Petersdorf, Prof. Brenda M. Sandmaier, Laura Connelly-Smith
Publikováno v:
Transplantation and Cellular Therapy. 29:S234-S235
Autor:
Jeannine S McCune, Saro H Armenian, Ryotaro Nakamura, Haoyue Shan, Christopher G Kanakry, Marco Mielcarek, Wei Gao, Donald E Mager
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311716
Introduction Medication nonadherence continues to be challenging for allogeneic hematopoietic cell transplant (HCT) recipients. The risk and severity of chronic graft-versus-host disease (GVHD) are associated with low immunosuppressant concentrations